Compare GSM & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSM | INMD |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United Kingdom | Israel |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 964.9M | 842.0M |
| IPO Year | 2015 | 2018 |
| Metric | GSM | INMD |
|---|---|---|
| Price | $4.19 | $13.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | $6.00 | ★ $16.75 |
| AVG Volume (30 Days) | ★ 1.3M | 1.0M |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | ★ 1.42% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.36 | $1.64 |
| Revenue Next Year | $17.85 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.04 | $12.72 |
| 52 Week High | $5.74 | $16.74 |
| Indicator | GSM | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 50.37 |
| Support Level | $4.10 | $13.26 |
| Resistance Level | $4.54 | $13.87 |
| Average True Range (ATR) | 0.22 | 0.26 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 56.25 | 71.81 |
Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.